focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: JPMorgan Raises Derwent, Cuts Shaftesbury

Fri, 15th Jan 2021 09:38

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

----------

FTSE 100

----------

UBS CUTS BT GROUP TO 'SELL' ('NEUTRAL') - TARGET 111 (116) PENCE

----------

LIBERUM RAISES WHITBREAD PRICE TARGET TO 3,000 (2,400) PENCE - 'HOLD'

----------

MORGAN STANLEY RAISES MELROSE INDUSTRIES TARGET TO 148 (140) PENCE - 'EQUAL-WEIGHT'

----------

DEUTSCHE BANK CUTS COCA-COLA HBC PRICE TARGET TO 2,800 (2,850) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS DIAGEO PRICE TARGET TO 3,850 (3,900) PENCE - 'BUY'

----------

BERENBERG RAISES DIAGEO PRICE TARGET TO 3,080 (2,810) PENCE - 'HOLD'

----------

JPMORGAN RAISES SEGRO PRICE TARGET TO 910 (880) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES LAND SECURITIES PRICE TARGET TO 800 (650) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES BRITISH LAND PRICE TARGET TO 500 (430) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES BP PRICE TARGET TO 415 (400) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ROYAL DUTCH SHELL PRICE TARGET TO 1,800 (1,700) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RESUMES TESCO WITH 'OVERWEIGHT' - TARGET 300 PENCE

----------

JPMORGAN RAISES BARCLAYS PRICE TARGET TO 180 (160) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK REINITIATES ASTRAZENECA WITH 'BUY' - PRICE TARGET 10,000 PENCE

----------

DEUTSCHE BANK REINITIATES GLAXOSMITHKLINE WITH 'HOLD' - PRICE TARGET 1,400 PENCE

----------

FTSE 250

----------

JPMORGAN RAISES WORKSPACE GROUP PRICE TARGET TO 855 (820) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ST MODWEN PROPERTIES TARGET TO 445 (390) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES LONDONMETRIC PROPERTY PRICE TARGET TO 230 (220) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS HAMMERSON PRICE TARGET TO 25 (30) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES GREAT PORTLAND PRICE TARGET TO 700 (630) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS CAPITAL & COUNTIES PRICE TARGET TO 135 (150) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS UNITE GROUP TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 950 PENCE

----------

JPMORGAN CUTS SHAFTESBURY TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 550 (900) PENCE

----------

JPMORGAN RAISES DERWENT LONDON TO 'NEUTRAL' ('UNDERWEIGHT') TARGET 3,200 (2,850) PENCE

----------

CREDIT SUISSE CUTS WOOD GROUP PRICE TARGET TO 320 (350) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES WOOD GROUP PRICE TARGET TO 400 (290) PENCE - 'BUY'

----------

LIBERUM RAISES HOWDEN JOINERY GROUP PRICE TARGET TO 780 (760) PENCE - 'BUY'

----------

JPMORGAN CUTS BABCOCK INTERNATIONAL PRICE TARGET TO 270 (335) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS BABCOCK INTERNATIONAL PRICE TARGET TO 355 (430) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES IMI PRICE TARGET TO 1,400 (1,320) PENCE - 'OVERWEIGHT

----------

DEUTSCHE BANK CUTS BRITVIC PRICE TARGET TO 930 (955) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES 888 HOLDINGS PRICE TARGET TO 340 (320) PENCE - 'BUY'

----------

RBC CUTS VESUVIUS TO 'SECTOR PERFORM' ('OUTPERFORM') - TARGET 550 (480) PENCE

----------

RBC CUTS BODYCOTE TO 'SECTOR PERFORM' ('OUTPERFORM') - TARGET 770 (710) P

----------

OTHER MAIN MARKET AND AIM

----------

CREDIT SUISSE RAISES BOOHOO PRICE TARGET TO 350 (300) PENCE - 'NEUTRAL'

----------

LIBERUM RAISES BOOHOO PRICE TARGET TO 380 (350) PENCE - 'HOLD'

----------

JEFFERIES RAISES LSL PROPERTY SERVICE PRICE TARGET TO 280 (243) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS FEVERTREE DRINKS PRICE TARGET TO 2,525 (2,550) PENCE - 'HOLD'

----------

JPMORGAN RAISES HELICAL TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 485 (460) PENCE

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.